Biogen's Drop Looks Like Overreaction
By Karen Andersen, CFA | 07-27-15 | 06:00 AM |
We think the market has overreacted to these developments. While we've slightly lowered our fair value estimate to $400 per share, we still think the shares are undervalued and the firm's wide economic moat is secure. We remain bullish on upcoming clinical data over a longer time horizon (2015-18) and think the firm has a promising collection of neurology-focused pipeline candidates.
The Motley Fool
SGYP Could Soon Rocket Higher
Key phase 3 catalyst is approaching for SGYP
Bio Invest or Google it
The Securities and Exchange Commission has divulged that Junius Daniel M, Director officer (Chief Executive Officer) of Immunogen Inc, had unloaded 5,416 shares at an average price of $14.34 in a transaction dated on July 1, 2015. The total value of the transaction was worth $77,665.
Mr Callahan Over 21 years experience in pharmaceutical COMMERCIALIZATION interesting he's aboard now.
The company, on July 01, 2015, reported that it has appointed Timothy Callahan and Richard Daly as new independent directors to its board. Both Mr. Callahan and Mr. Daly have direct experience in primary care and gastrointestinal markets and have led large organizational change and successful business growth, in a variety of areas, including all aspects of commercial, acquisitions, partnerships and product launches.
Mr. Callahan is a global life sciences business leader with over 21 years of experience in pharmaceutical and biologic commercialization, most recently with the Actavis organization.
ZIOP Breakout Chart LINK
ZIOP - Check Charts Shows ( ZIOP ) To Breakout // posted
See It Market
Trading Ideas: 5 Stocks To Watch For Breakouts
6/30/15 1:30 A.M. ( Chart and Link on Stocktwits ) ZIOPHARM Oncology (ZIOP) – A stock with impressive relative strength, ZIOP seems to be flagging for a breakout toward 14-15 and possibly beyond. Less
Wall Street Journal
Fitbit Isn’t Too Stretched
Fitbit’s valuation leaves the stock some room to run, even after scoring a nice IPO pop.
By Dan Gallagher
June 1823 2015
you don't have to have the phone on you, I use it all the time my phone can be at home and it still orks